Skip to content
  • Wednesday, 28 October 2026
  • 12:49 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Cellares and Papillon Therapeutics Partner to Automate Manufacturing of Investigational Therapy for Friedreich’s Ataxia
Pharmaceutical R&D

Cellares and Papillon Therapeutics Partner to Automate Manufacturing of Investigational Therapy for Friedreich’s Ataxia

Teuku Ryan Jul 23, 2026 0

In a significant development for the rare disease community, Cellares and Papillon Therapeutics have announced a strategic collaboration aimed at…

Read More
Neuroscience & Brain Research

Identification of CD99L2 Gene Variants as a Novel Driver of X-linked Spastic Ataxia Unlocks New Pathways in Neurodegenerative Research

Rifan Muazin Jun 23, 2026 0

In a significant breakthrough for the field of clinical genetics and neurology, a collaborative team of researchers in Germany has…

Read More
Neuroscience & Brain Research

German Researchers Identify CD99L2 Gene as Key Driver of X-linked Spastic Ataxia

Rifan Muazin Jun 14, 2026 0

In a major advancement for the field of neurogenetics, a collaborative team of scientists in Germany has identified a previously…

Read More
Science News: A Century of Empowering Public Understanding of ScienceJohnson and Johnson Raises 2026 Guidance for Sales and Earnings Despite Generic Headwinds and Major Legal and Acquisition OutlaysSalesforce Lands 140 Life Sciences Clients, Pitches ‘Headless’ AI to PharmaQuantum Fluctuations in a Vacuum Proven to Strengthen Superconductivity in Landmark Physics Study
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
The oral exposure challenge in PROTACs: What drug developers need to solve earlyThe Silence Broken: How Brain-Computer Interfaces are Restoring the Human Voice for Those Paralyzed by ALSESMO26: KEYNOTE-C93 Backs Chemo-Free Keytruda in dMMR Endometrial CancerThe Discovery of REM-like Sleep in Jumping Spiders Challenges Traditional Views of Animal Consciousness
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
The oral exposure challenge in PROTACs: What drug developers need to solve early
Lana Keisha Oct 28, 2026
Environmental & Analytical Chemistry
The Silence Broken: How Brain-Computer Interfaces are Restoring the Human Voice for Those Paralyzed by ALS
Abdurrohim Arsyad Oct 28, 2026
Pharmaceutical R&D
ESMO26: KEYNOTE-C93 Backs Chemo-Free Keytruda in dMMR Endometrial Cancer
Teuku Ryan Oct 28, 2026
Molecular & Cell Biology
The Discovery of REM-like Sleep in Jumping Spiders Challenges Traditional Views of Animal Consciousness
Angie Faith Oct 28, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ